Genomma Lab Internacional SAB de CVBMV: LAB/B

LAB/B: Sales declined due to hyperinflation and weak demand, but margins and cost controls remained strong

· Issued by Genomma Lab Internacional SAB de CV

Like-for-like sales fell 2.9% and net sales dropped 12.8% year-over-year, mainly due to hyperinflationary effects in Argentina and weak demand in Mexico, but EBITDA margin held at 23.7%. Productivity initiatives and cost controls supported resilience, with growth expected to resume in 1H 2026.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Genomma Lab Internacional SAB de CV on 6ix

Earlier from Genomma Lab Internacional SAB de CV

Later from Genomma Lab Internacional SAB de CV

All Genomma Lab Internacional SAB de CV news releases